Farrell Michael J. 4

What Happened
Michael J. Farrell, ResMed’s Chairman and CEO, exercised 4,991 stock option shares (report shows an acquisition at $146.34 per share, total cost $730,383) and sold the same 4,991 shares in an open-market transaction the same day for a weighted average price of $207.82 per share (total proceeds $1,037,233). The transactions were recorded on 2026-05-07.

Key Details

• Transaction date: 2026-05-07.
• Exercise: 4,991 shares acquired at $146.34 each (total $730,383).
• Sale: 4,991 shares sold at a weighted average $207.82 each (total $1,037,233); sale trades ranged $206.45–$210.47.
• Net proceeds before fees/taxes: ~ $306,850 (proceeds minus exercise cost).
• Filing: Form 4 filed 2026-05-11 (timely within the Form 4 reporting window).
• Shares owned after transaction: not disclosed in this filing.
• Footnotes: Transaction was executed under a pre-established Rule 10b5-1 plan adopted Oct 31, 2024. The filing notes the options’ first exercisable date and that they vest 1/3 per year.

Context
This is a same-day exercise-and-sell (effectively a cashless exercise) reported by the CEO and executed under a 10b5-1 plan, which typically reflects a pre-set trading arrangement rather than a discretionary trade. As with all insider filings, the transactions are factual records of activity and do not by themselves indicate the insider’s future view of the company.